alexa
Reach Us +441474556909
Co-Existence of Relapsing Remitting Multiple Sclerosis and HLA B27 Positive Ankylosing Spondylitis in a Malay Male: A Rare Occurrence | OMICS International | Abstract
ISSN: 2376-0389

Journal of Multiple Sclerosis
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Co-Existence of Relapsing Remitting Multiple Sclerosis and HLA B27 Positive Ankylosing Spondylitis in a Malay Male: A Rare Occurrence

Viswanathan S* and Kamil MKM

Hospital Kuala Lumpur, Department of Neurology, Jalan Pahang, Kuala Lumpur, MY 50586, Malaysia

*Corresponding Author:
Viswanathan S
Hospital Kuala Lumpur, Department of Neurology
Jalan Pahang, Kuala Lumpur, MY 50586, Malaysia
Tel: 60176800529
Email: [email protected]

Received date: February 27, 2017; Accepted date: March 23, 2017; Published date: March 30, 2017

Citation: Viswanathan S, Kamil MKM (2017) Co-Existence of Relapsing Remitting Multiple Sclerosis and HLA B27 Positive Ankylosing Spondylitis in a Malay Male: A Rare Occurrence. J Mult Scler 4:198. doi:10.4172/2376-0389.1000198

Copyright: © 2017 Viswanathan S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Ankylosing spondylitis (AS) and multiple sclerosis (MS) are two different chronic inflammatory autoimmune conditions with unclear etiopathogenesis. One is a rheumatological disorder while the other is a neurological one. Current literature on an association between these two conditions is limited. Furthermore, early recognition of potential cases with both conditions co-existing is important as there have been very rare reports on the occurrence of demyelinating diseases or unmasking of latent MS in patients with ankylosing spondylitis treated with anti-TNFα. This has important therapeutic implications for patients at such risk.

Top